Stay updated with breaking news from Nerve Protector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) CEO Karen L. Zaderej sold 39,280 shares of the stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $7.68, for a total value of $301,670.40. Following the completion of the transaction, the chief executive officer now directly owns 1,124,565 shares […]
AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) VP Michael Patrick Donovan sold 6,033 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $7.68, for a total value of $46,333.44. Following the completion of the transaction, the vice president now directly owns […]
AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) VP Michael Patrick Donovan sold 6,033 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $7.68, for a total transaction of $46,333.44. Following the sale, the vice president now owns 37,992 shares in the […]
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 -- Axogen, Inc. , a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making...
Company Also Announces Departure of Angelo Scopelianos, Ph.D.ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 -- Axogen, Inc. , a global leader in developing and marketing innovative surgical...